TUBERCULOUS PLEURAL EFFUSION MASQUERADING AS DRUG-INDUCED LUPUS
Chest
; 162(4):A365, 2022.
Article
in English
| EMBASE | ID: covidwho-2060575
ADAM protein; adenosine deaminase; chromium; cyclic citrullinated peptide antibody; endogenous compound; histone antibody; infliximab; mesalazine; rheumatoid factor; tumor necrosis factor antibody; unclassified drug; abnormal respiratory sound; adult; ankle; arthralgia; Bacilli; bacterium culture; blood culture; case report; case study; cell culture; clinical article; conference abstract; coronavirus disease 2019; coughing; cytology; diagnosis; diagnostic test accuracy study; drug therapy; drug toxicity; dyspnea; female; fever; gene expression; Gram staining; granulomatosis; human; human cell; hyperpigmentation; hypertension; immunogenicity; incidence; India; kidney; left lung; lupus like syndrome; lymphocyte; mediastinum lymph node; Mycobacterium tuberculosis; non insulin dependent diabetes mellitus; nonhuman; percussion; pleura effusion; pleura fluid; pleurisy; postprimary tuberculosis; predictive value; rheumatoid arthritis; rheumatology; sputum; surgery; swelling; systemic lupus erythematosus; thoracocentesis; thoracoscopy; thorax pain; tuberculosis; tuberculous pleurisy; ulcerative colitis
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Variants
Language:
English
Journal:
Chest
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS